期刊文献+

老龄男性血清PSA检测与组织病理免疫组化研究 被引量:2

Study on serum PSA determination and tissues pathology immunohistochemistry
下载PDF
导出
摘要 目的 以一汽集团 5 2 6名 5 0岁以上男性在职与离退休职工为受检对象 ,另以 10 1名 2 0~ 3 9岁年轻人和16名 40~ 49岁者为对照 ,研究前列腺特异性抗原 (PSA)与前列腺疾病的关系。方法 通过血清前列腺肿瘤标志物 -PSA含量测定 ,对血清PSA含量 >4 0ng/ml者与血清PSA含量正常 ,但前列腺体积明显增大伴有排尿困难者 ,采用经会阴四点穿刺取活体组织做病理与免疫组织化学分析。结果 血清PSA含量 >4 0ng/ml者占 15 0 9%。对活检的 40例病理标本检查发现 ,前列腺增生占 81 0 8%。前列腺癌的检出率为 0 95 %。结论  5 0岁以上人群Ⅱ度、Ⅲ度前列腺增生发现率 >60 %。前列腺癌的发现率约 1%。 Objective The treatise reported the PSA levels in the sera of 526 asymptomatic men(over 50 years old),16 men(age between 40-49) and 101 men(younger than 40years,control group) were determined.Methods Ninety-three men whose serum PSA levels were highere than 4.0?ng/ml were selected for biopsy.Tissues pathology analysis as well as PSA expression of prostatic tissues derived from biopsy were analyzed by methods of immunohistochemistry in biopsied men.Results Prostatic hyperplasia was 81.08% in 40 case sample,prostatic cancer was 0.95%.Conclusions The incidence rates of analysis benign prostatic hyperplasia was more than 60% and that of prostatic cancer was about 1% in men over 50 years old.
出处 《中国公共卫生》 CAS CSCD 北大核心 2003年第3期295-297,共3页 Chinese Journal of Public Health
关键词 前列腺特异性抗原 前列腺增生 前列腺癌 免疫组化 prostate specific antigen prostatic hyperplasia prostatic cancer immunohistochemistry
  • 相关文献

参考文献6

  • 1[1]Benson MC,Wha*!ng IS,Pantuck A,et al.Prostate specific antigen density:A means of disti*!nguishi*!ng benign prostatic hypertrophy and prostate cancer[J].J Unol,1992,147:815-816.
  • 2[2]Demura T,Shinohara N,Tanaka M,et al.The proportion of free to total prostate specific antigen:a medtod of detecti*!ng prostate carcinoma[J].Cancer,1996,77(6):1137-1143.
  • 3[3]Morote J,Raventos CX,Lorente JA,et al.Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostaye specific antigen specificity in prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10*!ng/ml[J].J Urol,1997,158(2):502-504.
  • 4[4]Diamandis ER.Prostate specific antigen:a cancer fighter and a valuable masse*!nger[J].Clin Chem,2000,7:896-900.
  • 5[5]Stege R,Grande M,Carlstrom K,et al.Prognostic significance of tissue prostate specific antigen in endocrine treated prostate carcinomas[J].Clin Cancer Res,2000,6:160-165.
  • 6[6]Murphy GP,Elganmal AA,Su SL,et al.Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen[J].Cancer, 1998,83:2259-2269.

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部